Harvard School of Public Health: Prenatal Exposure to Antiseizure Medication Topiramate May Not Increase Children's Risk of Autism Spectrum Disorder
March 21, 2024
March 21, 2024
BOSTON, Massachusetts, March 21 (TNSres) -- Harvard University's T.H. Chan School of Public Health issued the following news release:
Topiramate--an antiseizure medication prescribed to treat epilepsy as well as migraines and bipolar disorder--does not appear to increase the risk of autism spectrum disorder (ASD) among children exposed to it prenatally, according to a new study led by Harvard T.H. Chan School of Public Health.
The study was published online on March 20, . . .
Topiramate--an antiseizure medication prescribed to treat epilepsy as well as migraines and bipolar disorder--does not appear to increase the risk of autism spectrum disorder (ASD) among children exposed to it prenatally, according to a new study led by Harvard T.H. Chan School of Public Health.
The study was published online on March 20, . . .